Literature DB >> 18395658

The Congenital Diaphragmatic Hernia Study Group: a voluntary international registry.

KuoJen Tsao1, Kevin P Lally.   

Abstract

The Congenital Diaphragmatic Hernia Registry (CDHR) was established to collect data on all infants treated at participating institutions with congenital diaphragmatic hernia (CDH) to assess therapy and improve outcome. Since 1995, the CDHR has accumulated data on over 4000 infants. The collective efforts of the CDH Study Group have provided valuable information regarding the efficacy of various therapeutic interventions and have tried to establish predictors of outcome. Because CDH is an uncommon, heterogeneous structural anomaly with a wide spectrum of severity, individual institutions may vary significantly in their experiences and treatment approaches. International multicenter registries, like the CDHR, are useful to provide clinically relevant direction by accumulating far more data on a large patient population than any single institution might.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18395658     DOI: 10.1053/j.sempedsurg.2008.02.004

Source DB:  PubMed          Journal:  Semin Pediatr Surg        ISSN: 1055-8586            Impact factor:   2.754


  16 in total

1.  Efficacy of the circulatory management of an antenatally diagnosed congenital diaphragmatic hernia: outcomes of the proposed strategy.

Authors:  Noboru Inamura; Akio Kubota; Ryo Ishii; Yoichiro Ishii; Yukiko Kawazu; Yuji Hamamichi; Akihiro Yoneda; Hisayuki Kawahara; Hiroomi Okuyama; Futoshi Kayatani
Journal:  Pediatr Surg Int       Date:  2014-08-09       Impact factor: 1.827

2.  Looking beyond PPHN: the unmet challenge of chronic progressive pulmonary hypertension in the newborn.

Authors:  Candice D Fike; Judy L Aschner
Journal:  Pulm Circ       Date:  2013-11-19       Impact factor: 3.017

Review 3.  Surgical perspectives regarding application of biomaterials for the management of large congenital diaphragmatic hernia defects.

Authors:  Amulya K Saxena
Journal:  Pediatr Surg Int       Date:  2018-04-02       Impact factor: 1.827

4.  Correlation of MRI Brain Injury Findings with Neonatal Clinical Factors in Infants with Congenital Diaphragmatic Hernia.

Authors:  R Radhakrishnan; S Merhar; J Meinzen-Derr; B Haberman; F Y Lim; P Burns; E Zorn; B Kline-Fath
Journal:  AJNR Am J Neuroradiol       Date:  2016-05-05       Impact factor: 3.825

5.  Prenatal Factors Associated with Postnatal Brain Injury in Infants with Congenital Diaphragmatic Hernia.

Authors:  R Radhakrishnan; S L Merhar; W Su; B Zhang; P Burns; F Y Lim; B M Kline-Fath
Journal:  AJNR Am J Neuroradiol       Date:  2017-12-21       Impact factor: 3.825

6.  Patch repair is an independent predictor of morbidity and mortality in congenital diaphragmatic hernia.

Authors:  M E Brindle; M Brar; E D Skarsgard
Journal:  Pediatr Surg Int       Date:  2011-05-18       Impact factor: 1.827

7.  Defect-diaphragmatic ratio: a new parameter for assessment of defect size in neonates with congenital diaphragmatic hernia.

Authors:  M Rygl; P Kuklova; D Zemkova; K Slaby; K Pycha; Z Stranak; J Melichar; J Snajdauf
Journal:  Pediatr Surg Int       Date:  2012-07-03       Impact factor: 1.827

8.  The Utility of Serial Echocardiography Parameters in Management of Newborns with Congenital Diaphragmatic Hernia (CDH) and Predictors of Mortality.

Authors:  Roopali Soni; Naharmal Soni; Aravanan Chakkarapani; Samir Gupta; Phani Kiran Yajamanyam; Sanoj K M Ali; Mohammed El Anbari; Moath Alhamad; Dhullipala Anand; Kiran More
Journal:  Pediatr Cardiol       Date:  2022-09-27       Impact factor: 1.838

9.  Thoracoscopic repair of congenital diaphragmatic hernia in infancy.

Authors:  Oliver B Lao; Matthew R Crouthamel; Adam B Goldin; Robert S Sawin; John H T Waldhausen; Stephen S Kim
Journal:  J Laparoendosc Adv Surg Tech A       Date:  2010-04       Impact factor: 1.878

10.  Protective effect of baicalin on fetal lung development in a rabbit model of congenital diaphragmatic hernia.

Authors:  Hailong Su; Linsong Mu; Changsheng Liu
Journal:  Exp Ther Med       Date:  2017-10-31       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.